Page URL:

Non-invasive prenatal test for Down's syndrome developed

13 October 2008
Appeared in BioNews 479

Scientists at Stanford University in California, US have developed a new non-invasive prenatal test for Down's syndrome. Stephen Quake and colleagues successfully identified presence and absence of fetal chromosomal abnormality in 18 pregnant women from maternal blood samples. The work is published this month in the journal Proceedings of the National Academy of Sciences.

Currently, the two techniques available for prenatal diagnosis of Down's syndrome are both invasive and carry a risk of miscarriage. CVS (chorionic villus sampling) and amniocentesis carry a two per cent and one per cent chance of miscarriage respectively. Dr Quake's procedure does not bring any risk of miscarriage and can also be performed at an earlier point in pregnancy (a few weeks as opposed to ten and 15 weeks for CVS and amniocentesis). Earlier diagnosis of Down's syndrome would also allow parents more time to think about test results - especially important if they are considering terminating an affected pregnancy.

As well as being less invasive and accurate at an earlier stage in pregnancy, Dr Quake's test would also be simpler and less expensive to perform than test currently available. Dr Lyn Chitty, an expert in genetics and fetal medicine at University College London Hospital, said: 'This is a potentially exciting development which may take us closer to a safer, non-invasive test for Down's syndrome'. Earlier prenatal tests would also improve the management of treatable conditions such as congenital adrenal hyperplasia (CAH), which causes the genitalia of female fetuses to develop abnormally. CAH can easily be treated with steroids during pregnancy if diagnosed.

Down's syndrome occurs when a fetus has three copies of chromosome 21 instead of two. Dr Quake's method uses 'shotgun sequencing' to sequence short fragments of 'cell-free' fetal DNA present in the mother's blood. The fragments can then be matched to specific chromosomes and the proportion from chromosome 21 determined. It is still early days, however, and Dr Quake is keen to run larger studies to verify these exciting initial findings.

An alternative method which relies on determining if equal amounts of chromosome 21 come from each parent is already being commercialised in the US. However, that method, developed by Dr Dennis Lo of the Chinese University in Hong Kong, is optimised for the US population, which has a different ethnic structure to other countries, so the current test may not work as effectively outside the US. It also relies upon having the father present and available for testing as well as the mother. Dr Quake's test does not suffer from these limitations, 'Our approach works on 100% of the population, independent of ethnicity', he said.

Blood tests could eliminate Down's miscarriage risk
New Scientist |  6 October 2008
New blood tests for Down's syndrome
Press Association |  7 October 2008
'Safer' test developed for Down's
BBC News Online |  6 October 2008
Scientists hail non-invasive Down's syndrome test for pregnant women
The Times |  7 October 2008
14 January 2013 - by Dr Daniel Grimes 
US biotech company Verinata Health has reported sequencing fetal DNA taken from pregnant women's blood to test for genetic abnormalities...
10 December 2012 - by Dr Lux Fatimathas 
More sensitive prenatal testing of fetal DNA could improve the detection of genetic diseases, studies find...
9 July 2012 - by Dr Lux Fatimathas 
US researchers have for the first time sequenced the genome of a fetus using only a blood sample from the mother. It is hoped this new form of non-invasive sampling could allow doctors to screen for a range of genetic diseases prenatally, with minimal risk to the fetus...
27 June 2011 - by Nkechi Nwachukwu 
In this ambitious text, Eleanor Milligan peels back the ethical layers surrounding prenatal screening. She reveals a world in which women choosing if they should undergo prenatal screening are heavily influenced by social considerations and often demonstrate a lack of understanding about the technique. By exploring the many ethical factors which influence a woman's decision to undergo prenatal screening, Milligan highlights how many women who partake do so without truly giving their ...
28 June 2010 - by Laura Riley 
The UK's Royal College of Obstetricians and Gynaecologists (RCOG) has released a Working Party report, Termination of Pregnancy for Fetal Abnormality. The report found that it was not 'realistic' to seek to produce a definitive list of conditions that constitute 'serious handicap' for clinicians to use in interpreting the legal grounds for abortion under the 1967 Abortion Act...
29 September 2008 - by Ailsa Stevens 
A decade ago, it was found that the blood of pregnant women contains DNA from the fetus. The discovery of this 'free fetal DNA' (ffDNA) has led to the development of non-invasive prenatal diagnosis, where genetic characteristics of the fetus can be analysed a mere few weeks into pregnancy by...
15 September 2008 - by Jane Fisher 
Antenatal Results and Choices (ARC) is the only UK charity providing non-directive information and support to parents before, during and after antenatal testing and when an abnormality is diagnosed in an unborn baby. We have 20 years' experience of talking to parents on our National Helpline on all aspects of...
15 September 2008 - by Tessa Homfray 
The holy grail of prenatal diagnosis has been the identification of chromosome and single gene abnormalities through maternal blood sampling. This would allow safe accurate prenatal diagnosis, requiring much lower operator skills, and automation is potentially possible, making it cost-effective. In contrast, standard prenatal screening involves ultrasound and biochemical risk...
16 June 2008 - by Dr Philippa Brice 
Antenatal care in the UK includes various forms of screening intended to assess the health of the mother and fetus; at present this includes the use of ultrasound imaging to check on physical development of the fetus, and serum screening using maternal blood to determine blood group, identify the presence...
16 June 2008 - by Dr Zuzana Deans and Dr Ainsley Newson 
Dr Phillipa Brice's accompanying commentary highlights how non-invasive testing of free fetal DNA (ffDNA) in pregnancy could transform women's experiences of antenatal screening and prenatal diagnosis. NIPD is already available for foetal sex, rhesus D blood type and some Mendelian conditions such as achondroplasia, with tests for aneuploidy detection and...
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.